Drugmakers Turn to Data Mining to Avoid Expensive, Lengthy Drug Trials

Drugmakers are trying to win drug approvals by parsing vast data sets of electronic medical records, shifting away from lengthy, and costly, clinical trials in patients.

Pfizer Inc., Johnson & Johnson and Amgen Inc. are among the drugmakers that have submitted the data-mining analyses to the U.S. Food and Drug Administration in seeking approval to sell new medicines or for new uses for older ones. The FDA has approved new uses for breast cancer, bladder cancer and leukemia drugs in part based on the data.

Is this a HIPAA violation?

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tattoo removal company seeks to ride a wave of millennial 'regretters'Tattoo removal treatment has remained an expensive and painful procedure for decades. No regret here . Regret is inter-generational I wanna see them paragraphs upon paragraphs tattoos removed from people 🤣
Source: CNBC - 🏆 12. / 72 Read more »